FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Category Archives: News

  • Home
  •  | 
  • Category Archives: "News"

PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders

PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders
PharmaTher Inc., (“PharmaTher” or the “Company”), a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) (OTC Pink: PHRRF) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that it has filed a provisional patent application with the U.S. Patent and Trademark Office outlining the potential for novel combinations of psilocybin and U.S. Food and Drug Administration (“FDA”) approved drugs to treat neurological disorders.
Read more

A healthy investment? The rising popularity of cannabis vape pens.

A healthy investment? The rising popularity of cannabis vape pens.
A healthy investment? The rising popularity of cannabis vape pens. By Clint Sharples, CEO, Heritage Cannabis Since the introduction of “Cannabis 2.0” to Canada’s legal cannabis market, vape pens have quickly become one of the most popular ways to consume cannabis. Cannabis 1.0 — chiefly unprocessed flower and pre-rolled joints — still make up roughly…
Read more